Brain health is defined by the World Health Organization as the promotion of optimal brain development, cognitive health, and well-being for across the life course. This definition implies that brain health comprises more than simply being free from illness or disability, and emphasizes a holistic approach focused on promotion, prevention, treatment, care, and rehabilitation.
The Brain Health Innovation Summit took place in Rome, Italy, on 24 and 25 November. Three speakers from DPAG attended, Professor Zoltan Molnar, Dr Auguste Vadisiute and Dr Fernando Messore. The two main organisers and chairs of the meeting were Professor Belinda Lennox (Department of Psychiatry) and Professor Kevin Talbot (Nuffield Department of Clinical Neurosciences) and it was sponsored by Angelini Pharma and Brain Heath.
The goal of the event was to bring together key people working in the brain health space to share the latest advances in brain health research, and to discuss forward looking strategic directions. The aim was to leverage the expertise of researchers and clinicians working in brain health research, to explore new frontiers in brain health, and to develop the evidence needed to advance in the field of psychiatric and neurological diseases, which represent a very real health challenge for today and tomorrow.
The meeting provided an invaluable opportunity to share information on the latest research, insights, and best practices related to brain health; to facilitate networking opportunities and interdisciplinary discussions for psychiatrists, neurologists, and industry leaders thus fostering collaboration in the brain health field; and to build a foundation for a sustained task force focused on driving progress in brain health initiatives.
Professor Kevin Talbot commented, 'From the lively discussion at this meeting it was clear that the distinction between neurology and psychiatry is artificial. Scientists and clinicians can be more productive by working together for the benefit of patients with brain disorders.'